ARCHIVES

FDA Approves Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 33 | September 14, 2007

Download PDF Visit The Full Archive

Related Articles

Non-Caucasians At Higher Risk For Severe Breast Cancer Pain

December 28, 2007

Cancer Education Applications Suspended Pending Restructuring

March 21, 1986

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

NIDA Supports Phase III Trial of Anti-Tobacco Vaccine

November 6, 2009

Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter

October 15, 1976

CTI Files Appeal Over FDA’s Decision on Pixantrone

December 3, 2010